Cargando…
Enhancement of liver-directed transgene expression at initial and repeat doses of AAV vectors admixed with ImmTOR nanoparticles
Systemic AAV (adeno-associated virus) gene therapy is a promising approach for the treatment of inborn errors of metabolism, but questions remain regarding its potency and durability. Tolerogenic ImmTOR nanoparticles encapsulating rapamycin have been shown to block the formation of neutralizing anti...
Autores principales: | Ilyinskii, Petr O., Michaud, Alicia M., Roy, Christopher J., Rizzo, Gina L., Elkins, Stephanie L., Capela, Teresa, Chowdhury, Aparajita C., Leung, Sheldon S., Kishimoto, Takashi K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904260/ https://www.ncbi.nlm.nih.gov/pubmed/33627416 http://dx.doi.org/10.1126/sciadv.abd0321 |
Ejemplares similares
-
ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemia
por: Ilyinskii, Petr O., et al.
Publicado: (2021) -
Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles
por: Ilyinskii, Petr O., et al.
Publicado: (2021) -
Readministration of high-dose adeno-associated virus gene therapy vectors enabled by ImmTOR nanoparticles combined with B cell-targeted agents
por: Ilyinskii, Petr O, et al.
Publicado: (2023) -
Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies
por: Kishimoto, Takashi Kei
Publicado: (2020) -
Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis
por: Freitas, Elisangela Oliveira, et al.
Publicado: (2015)